Journal
JOURNAL OF IMMUNOLOGY
Volume 192, Issue 7, Pages 3280-3288Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1301751
Keywords
-
Categories
Funding
- University of California San Francisco (UCSF) Resource Allocation Program
- American Heart Association
- UCSF Sandler Asthma Basic Research Center
Ask authors/readers for more resources
Dendritic cells (DCs) play an important role in immune homeostasis through their ability to present Ags at steady state and mediate T cell tolerance. This characteristic renders DCs an attractive therapeutic target for the induction of tolerance against auto-antigens or allergens. Accordingly, Ag-conjugated DC-specific Abs have been proposed to be an excellent vehicle to deliver Ags to DCs for presentation and tolerance induction. However, this approach requires laborious reagent generation procedures and entails unpredictable side effects resulting from Ab-induced crosslinking of DC surface molecules. In this study, we examined whether IgE, a high-affinity, non-cross-linking natural ligand of Fc epsilon RI, could be used to target Ags to DCs and to induce Ag-specific T cell tolerance. We found that Ag-conjugated human IgE Fc domain (Fc epsilon) effectively delivered Ags to DCs and enhanced Ag presentation by 1000- to 2500-fold in human Fc epsilon RI alpha-transgenic mice. Importantly, this presentation resulted in a systemic deletion of Ag-specific T cells and prevented these mice from developing delayed-type hypersensitivity, which is critically dependent on Ag-specific T cell immunity. Thus, targeting Fc epsilon RI on DCs via Ag-Fc epsilon fusion protein may serve an alternative method to induce Ag-specific T cell tolerance in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available